Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None AUD 0.00(0%)
Last update at 2025-08-14T06:45:03.485394Z
Market Cap
51.98M

Momentum Score

…

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company was incorporated in 1987 and is based in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.03
Low
0.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
1.85M
Revenue Per Share
0.00
Gross Profit TTM
1.55M
Debt / Equity
0.04
ROE
-181.82%
Net Debt
-0.65M
ROCE
-208.34%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -5.78M -6.62M -11.04M -7.26M -7.47M
Net income -5.78M -6.62M -11.04M -7.26M -6.46M
Selling general administrative 4.83M 3.77M 5.84M 5.91M 2.41M
Selling and marketing expenses 0.22M 0.92M 2.19M 0.78M 0.85M
Gross profit 0.00M -0.01M -0.99M -0.99M 1.03M
Reconciled depreciation 0.08M 0.08M 0.08M 0.01M 0.00M
Ebit -5.76M -7.07M -12.16M -9.46M -8.48M
Ebitda -5.68M -6.99M -12.08M -9.45M -8.48M
Depreciation and amortization 0.08M 0.08M 0.08M 0.01M 0.00M
Operating income -5.76M -6.63M -11.09M -9.46M -8.48M
Other operating expenses 6.29M 6.88M 9.90M 9.46M 8.48M
Interest expense 0.01M 0.45M 0.00M 0.00M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.02M 0.08M 0.05M 0.01M 0.02M
Net interest income -0.01M - - 0.00M 0.01M
Income tax expense 0.61M -0.45M -1.12M -0.00M -1.01M
Total revenue 0.07M 0.25M 0.27M 0.27M 1.03M
Total operating expenses 6.36M 7.07M 11.17M 9.46M 8.48M
Cost of revenue 0.07M 0.26M 1.26M 1.26M -
Total other income expense net 0.59M 0.45M 1.12M 2.20M 1.01M
Net income from continuing ops -5.78M -6.62M -11.04M -7.26M -8.47M
Net income applicable to common shares -5.78M -6.62M -11.04M -7.26M -8.47M
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 6.19M 3.18M 4.21M 9.11M 4.62M
Other current assets 0.27M 1.42M 0.03M 0.11M 0.37M
Total liab 3.55M 2.35M 1.20M 1.54M 2.12M
Total stockholder equity 2.64M 0.83M 3.01M 7.57M 2.49M
Other current liab 1.38M 0.63M 0.60M 0.31M 0.10M
Common stock 140.55M 132.10M 128.84M 127.09M 113.69M
Capital stock - 132.10M 128.84M 127.09M 113.69M
Retained earnings -141.92M -138.05M -133.31M -126.35M -115.31M
Other liab - - - - 0.13M
Other assets 0.00M - - 0.00M 0.00M
Cash 0.76M 0.15M 1.22M 7.97M 3.55M
Cash and equivalents - - - 7.97M -
Total current liabilities 3.43M 2.24M 1.20M 1.47M 2.00M
Current deferred revenue 0.05M 0.06M 0.00M 0.00M 0.26M
Net debt -0.65M 0.00M -1.15M -7.83M -2.66M
Short term debt 0.06M 0.03M 0.07M 0.07M 0.76M
Short long term debt - - - - 0.72M
Short long term debt total 0.12M 0.15M 0.07M 0.14M 0.89M
Other stockholder equity - -0.00M 7.48M -0.74M 4.11M
Property plant equipment - 0.18M 0.08M 0.16M 0.19M
Total current assets 4.03M 3.00M 4.12M 8.95M 4.43M
Net tangible assets - 0.83M 3.01M 7.57M 2.49M
Short term investments - 0.03M 0.03M 0.54M 0.05M
Net receivables 0.25M 0.05M 0.05M 0.14M 0.01M
Long term debt - - 0.00M - -
Inventory 2.75M 1.23M 2.65M 0.54M 0.31M
Accounts payable 1.94M 1.51M 0.52M 1.08M 0.87M
Accumulated other comprehensive income 4.01M 6.78M 7.48M 6.83M 4.11M
Common stock total equity - - - - 113.69M
Non currrent assets other 2.04M -0.18M -0.08M 0.50M 0.00M
Non current assets total 2.16M 0.18M 0.08M 0.16M 0.19M
Capital lease obligations - 0.15M 0.07M 0.14M 0.18M
Long term debt total - 0.12M 0.00M 0.07M 0.13M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.02M -0.00M -0.05M -0.01M -0.00M
Change to liabilities 1.12M -0.50M 0.16M -0.63M 0.76M
Total cashflows from investing activities -0.02M -0.00M -0.05M -0.01M -0.00M
Net borrowings 0.20M 0.20M -0.74M -0.15M 0.80M
Total cash from financing activities 3.46M 1.64M 11.79M 7.96M 4.33M
Change to operating activities -0.30M 0.26M 0.23M -0.03M -0.42M
Net income -5.78M -6.62M -11.04M -7.26M -8.47M
Change in cash -1.07M -6.76M 4.42M 3.25M -2.11M
Begin period cash flow 1.22M 7.97M 3.55M 0.31M 2.42M
End period cash flow 0.15M 1.22M 7.97M 3.55M 0.31M
Total cash from operating activities -4.49M -8.48M -7.34M -4.69M -6.41M
Issuance of capital stock 3.65M 1.67M 13.08M 8.53M 3.75M
Depreciation 0.08M 0.08M 0.08M 0.01M 0.00M
Other cashflows from investing activities - - - - 0.00M
Dividends paid - - 11.79M 7.96M 0.15M
Change to inventory 0.03M -2.11M -0.23M -0.31M -0.31M
Change to account receivables 0.00M 0.09M -0.06M 0.15M -0.04M
Sale purchase of stock -0.39M -0.03M -0.55M -0.43M -0.22M
Other cashflows from financing activities 0.20M -0.00M -0.05M -0.01M 1.09M
Change to netincome 0.35M 0.34M 3.51M 3.37M 1.76M
Capital expenditures 0.02M 0.00M 0.05M 0.01M 0.00M
Change in working capital 0.03M -2.03M -0.29M -0.16M 1.03M
Stock based compensation 0.34M 0.42M 3.53M 3.27M -
Other non cash items 1.21M -1.94M 3.62M 2.56M 8.47M
Free cash flow -4.51M -8.48M -7.39M -4.70M -6.41M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
COH
Cochlear Ltd
2.26
1.50%
152.98 68.64 27.40 4.30 5.34 3.97 28.09
IMR
Imricor Medical Systems Inc
0.06
4.72%
1.33 - - 36401.21 17.45 4019.33 -2.60
AVR
Anteris Technologies Global Corp
0.50
5.88%
9.00 - - 356.02 2.19 130.34 -5.20
AVH
Avita Medical Inc
-0.11
2.13%
5.06 - 9.97 9.59 7.17 6.76 15.37

Profile*

Respiri Ltd

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company was incorporated in 1987 and is based in Melbourne, Australia.

432 St Kilda Road, Melbourne, VIC, Australia, 3004

61 3 9653 9160

Name Title Year Born
Mr. Nicholas Smedley Exec. Chairman NA
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO, MD & Exec. Director NA
Mr. George Vlachodimitropoulos Chief Technology Officer NA
Mr. Theo Antonopoulos Chief Commercial Officer NA
Mr. Andrew Metcalfe CPA Company Sec. NA
Prof. Noam Gavriely Medical & Scientific Advisor NA
Mr. Simon Godfrey Medical & Scientific Advisor NA
Mr. Philippe Ludekens Gen. Mang. of Commercial Operations NA
Mr. Nicholas Smedley Executive Chairman NA
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO, MD & Executive Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…